PK/PD of Vazalore vs IR Aspirin in Healthy Volunteers

Phase 1, randomised, open-label trial of omecamtiv mecarbil in cardiovascular disease (CVD) and thrombosis (4 arms), sponsored by PLx Pharma Inc. Primary endpoints: Area Under the Curve from time 0 to last measurable concentration at 24 hours, Area Under the Curve from time 0 to infinity at 24 hours and 4 more. Started Feb 2008; status: completed.